Search for Clinical Trial Results

Cholangitis, Sclerosing - 25 Studies Found
Status | Study |
Completed |
Study Name: Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis Condition: Cholangitis, Sclerosing Date: 2011-10-14 Interventions: Drug: Oral all-trans retinoic acid (ATRA) The subjects wil |
Recruiting |
Study Name: Swiss Primary Sclerosing Cholangitis Cohort Study Condition: Cholangitis, Sclerosing Date: 2017-05-08 |
Completed |
Study Name: Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis Condition: Cholangitis, Sclerosing Date: 2000-02-24 Interventions: Drug: cladribine |
Recruiting |
Study Name: Quality of Life in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-03-11 Interventions: Other: quality of life survey subjects with PSC will be administered a survey to assess their quality of |
Completed |
Study Name: Cholangioscopy Using Narrow Band Imaging (NBI) in Patients With Primary Sclerosing Cholangitis (PSC) Undergoing Endoscopic Retrograde Cholangiopancreatogram (ERCP) Condition: Primary Sclerosing Cholangitis Date: 2009-07-31 |
Recruiting |
Study Name: Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis. Condition: Sclerosing Cholangitis Date: 2015-04-18 Interventions: Biological: Fecal Microbiota Transplantation |
Completed |
Study Name: Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC) Condition: Sclerosing Cholangitis Date: 2012-03-14 |
Completed |
Study Name: Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC) Condition: Primary Sclerosing Cholangitis Date: 2014-09-05 |
Recruiting |
Study Name: PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-01-08 Interventions: Drug: Cenicriviroc 150 mg One tablet of CVC 150 mg once daily taken with food in the morning |
Withdrawn |
Study Name: The Value of CT Cholangiography in Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2007-12-26 Interventions: Procedure: CT cholangiography Cholografin 20ml will be diluted in 100 ml of normal saline and infused ov |